The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells
出版年份 2021 全文链接
标题
The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells
作者
关键词
-
出版物
MOLECULES
Volume 26, Issue 7, Pages 2045
出版商
MDPI AG
发表日期
2021-04-04
DOI
10.3390/molecules26072045
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancer
- (2020) Sanne CFA Huijberts et al. Future Oncology
- The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells
- (2020) Agnieszka Gornowicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-e][1,2,4]triazine Derivatives
- (2020) Zofia Bernat et al. MOLECULES
- mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
- (2019) Tian Tian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA ‐A24‐positive pancreatic adenocarcinoma
- (2019) Hiroaki Shima et al. CANCER SCIENCE
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Monoclonal anti‑MUC1 antibody with novel octahydropyrazino[2,1‑a:5,4‑a']diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer cells
- (2019) Agnieszka Gornowicz et al. ONCOLOGY REPORTS
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer
- (2018) Thomas N.Y. Kwong et al. GASTROENTEROLOGY
- The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivatives in human gastric cancer cells
- (2018) Natalia Pawłowska et al. INVESTIGATIONAL NEW DRUGS
- Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells
- (2018) Ismail Koyuncu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Soluble intercellular adhesion molecule-1 is a prognostic marker in colorectal carcinoma
- (2018) Vera S. Schellerer et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Effects of Beclin 1 overexpression on aggressive phenotypes of colon cancer cells
- (2018) Mei‑Ying Zhang et al. Oncology Letters
- An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds
- (2017) Stella Cascioferro et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives
- (2017) Stella Cascioferro et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 1,3,5-Triazines: A promising scaffold for anticancer drugs development
- (2017) Stella Cascioferro et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biological evaluation of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives as potent anticancer agents
- (2017) Agnieszka Gornowicz et al. TUMOR BIOLOGY
- Anticancer Effect of a Novel Octahydropyrazino[2,1-a:5,4-a′]diisoquinoline Derivative and Its Synergistic Action with Nigella sativa in Human Gastric Cancer Cells
- (2017) Anna Czajkowska et al. Biomed Research International
- New pyrazolo[4,3- e ][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors
- (2015) Mariusz Mojzych et al. BIOORGANIC & MEDICINAL CHEMISTRY
- FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
- (2015) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
- (2015) Thomas J. Kipps et al. LEUKEMIA & LYMPHOMA
- The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells
- (2015) Agnieszka Gornowicz et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives in human breast cancer cells
- (2014) Monika Lepiarczyk et al. ARCHIVES OF PHARMACAL RESEARCH
- Synthesis of pyrazolo[4,3- e ][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity
- (2014) Mariusz Mojzych et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeting cell death signaling in colorectal cancer: Current strategies and future perspectives
- (2014) Bruno Christian Koehler WORLD JOURNAL OF GASTROENTEROLOGY
- Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma
- (2014) Richard Joseph et al. Drug Design Development and Therapy
- The BH3 mimetic ABT-263 synergizes with the MEK1/2 inhibitor selumetinib/AZD6244 to promote BIM-dependent tumour cell death and inhibit acquired resistance
- (2012) Matthew J. Sale et al. BIOCHEMICAL JOURNAL
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
- Decreased Beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung
- (2011) Kyu Yeoun Won et al. HUMAN PATHOLOGY
- Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
- (2011) Greg Yothers et al. JOURNAL OF CLINICAL ONCOLOGY
- The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo
- (2011) J. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study
- (2010) Paola Matarrese et al. Molecular Cancer
- Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice
- (2010) L Sevenich et al. ONCOGENE
- Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice
- (2010) L. Sevenich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor
- (2009) Peter Gimsing EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Role of Sulfonamide Group in Matrix Metalloproteinase Inhibitors
- (2008) Xian-Chao Cheng et al. CURRENT MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More